Leonid Timashev
Stock Analyst at RBC Capital
(4.52)
# 286
Out of 5,105 analysts
131
Total ratings
56.9%
Success rate
19.84%
Average return
Main Sectors:
Stocks Rated by Leonid Timashev
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DSGN Design Therapeutics | Upgrades: Outperform | $6 → $13 | $9.43 | +37.86% | 10 | Nov 20, 2025 | |
| ONC BeOne Medicines AG | Maintains: Outperform | $395 → $408 | $319.06 | +27.88% | 5 | Nov 18, 2025 | |
| CGON CG Oncology | Maintains: Outperform | $53 → $61 | $40.94 | +49.00% | 2 | Nov 17, 2025 | |
| LEGN Legend Biotech | Maintains: Outperform | $75 → $74 | $22.32 | +231.54% | 14 | Nov 13, 2025 | |
| JSPR Jasper Therapeutics | Maintains: Sector Perform | $5 → $4 | $1.77 | +125.99% | 1 | Nov 11, 2025 | |
| CYTK Cytokinetics | Maintains: Outperform | $82 → $87 | $63.35 | +37.33% | 4 | Nov 11, 2025 | |
| EWTX Edgewise Therapeutics | Maintains: Outperform | $49 → $50 | $23.62 | +111.69% | 15 | Nov 7, 2025 | |
| XNCR Xencor | Maintains: Outperform | $18 → $19 | $16.52 | +15.01% | 3 | Nov 6, 2025 | |
| NAMS NewAmsterdam Pharma Company | Maintains: Outperform | $39 → $44 | $37.25 | +18.12% | 8 | Nov 6, 2025 | |
| JAZZ Jazz Pharmaceuticals | Maintains: Outperform | $151 → $155 | $167.50 | -7.46% | 2 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $19 → $9 | $11.53 | -21.94% | 13 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $7 → $8 | $8.43 | -5.10% | 3 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $189 → $198 | $148.17 | +33.63% | 14 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $77 | $78.92 | -2.43% | 1 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $139 → $215 | $197.01 | +9.13% | 6 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Perform | $27 → $11 | $7.45 | +47.65% | 2 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $45 → $47 | $28.50 | +64.91% | 5 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Sector Perform | $45 | $40.88 | +10.08% | 2 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $21 → $22 | $11.49 | +91.47% | 2 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $38 → $41 | $34.03 | +20.48% | 3 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $12 → $13 | $9.61 | +35.28% | 2 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $8 → $5 | $4.23 | +18.20% | 1 | Jun 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $15 → $16 | $2.67 | +499.25% | 1 | Jun 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $8 | $4.30 | +86.05% | 6 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 | $1.23 | +143.90% | 1 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Sector Perform | $70 | $95.41 | -26.63% | 1 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $18 | $6.74 | +167.06% | 4 | Jan 15, 2025 |
Design Therapeutics
Nov 20, 2025
Upgrades: Outperform
Price Target: $6 → $13
Current: $9.43
Upside: +37.86%
BeOne Medicines AG
Nov 18, 2025
Maintains: Outperform
Price Target: $395 → $408
Current: $319.06
Upside: +27.88%
CG Oncology
Nov 17, 2025
Maintains: Outperform
Price Target: $53 → $61
Current: $40.94
Upside: +49.00%
Legend Biotech
Nov 13, 2025
Maintains: Outperform
Price Target: $75 → $74
Current: $22.32
Upside: +231.54%
Jasper Therapeutics
Nov 11, 2025
Maintains: Sector Perform
Price Target: $5 → $4
Current: $1.77
Upside: +125.99%
Cytokinetics
Nov 11, 2025
Maintains: Outperform
Price Target: $82 → $87
Current: $63.35
Upside: +37.33%
Edgewise Therapeutics
Nov 7, 2025
Maintains: Outperform
Price Target: $49 → $50
Current: $23.62
Upside: +111.69%
Xencor
Nov 6, 2025
Maintains: Outperform
Price Target: $18 → $19
Current: $16.52
Upside: +15.01%
NewAmsterdam Pharma Company
Nov 6, 2025
Maintains: Outperform
Price Target: $39 → $44
Current: $37.25
Upside: +18.12%
Jazz Pharmaceuticals
Nov 6, 2025
Maintains: Outperform
Price Target: $151 → $155
Current: $167.50
Upside: -7.46%
Nov 6, 2025
Maintains: Sector Perform
Price Target: $19 → $9
Current: $11.53
Upside: -21.94%
Nov 4, 2025
Maintains: Outperform
Price Target: $7 → $8
Current: $8.43
Upside: -5.10%
Nov 4, 2025
Maintains: Outperform
Price Target: $189 → $198
Current: $148.17
Upside: +33.63%
Nov 3, 2025
Initiates: Outperform
Price Target: $77
Current: $78.92
Upside: -2.43%
Oct 31, 2025
Maintains: Outperform
Price Target: $139 → $215
Current: $197.01
Upside: +9.13%
Oct 31, 2025
Downgrades: Sector Perform
Price Target: $27 → $11
Current: $7.45
Upside: +47.65%
Oct 23, 2025
Maintains: Outperform
Price Target: $45 → $47
Current: $28.50
Upside: +64.91%
Oct 21, 2025
Reiterates: Sector Perform
Price Target: $45
Current: $40.88
Upside: +10.08%
Oct 21, 2025
Maintains: Outperform
Price Target: $21 → $22
Current: $11.49
Upside: +91.47%
Oct 21, 2025
Maintains: Outperform
Price Target: $38 → $41
Current: $34.03
Upside: +20.48%
Aug 8, 2025
Maintains: Outperform
Price Target: $12 → $13
Current: $9.61
Upside: +35.28%
Jun 20, 2025
Maintains: Outperform
Price Target: $8 → $5
Current: $4.23
Upside: +18.20%
Jun 3, 2025
Maintains: Outperform
Price Target: $15 → $16
Current: $2.67
Upside: +499.25%
Mar 19, 2025
Reiterates: Outperform
Price Target: $8
Current: $4.30
Upside: +86.05%
Mar 19, 2025
Maintains: Buy
Price Target: $3
Current: $1.23
Upside: +143.90%
Jan 23, 2025
Reiterates: Sector Perform
Price Target: $70
Current: $95.41
Upside: -26.63%
Jan 15, 2025
Reiterates: Outperform
Price Target: $18
Current: $6.74
Upside: +167.06%